Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Open accessThe DOI matches its Crossref record; 564 of the 564 references it cites were found in a registry or an index.
Abstract
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accurately diagnosing sepsis is challenging as sepsis can present in subtle ways, and some presentations that first appear to be sepsis turn out to be noninfectious conditions (90, 93, 107, 108).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [108]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Daily chlorhexidine bathing of ICU patients decreases risk of bloodstream infections in general, including candidemia.125,164”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [125]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mainstay of treatment for most cases of uncomplicated VVC is azole antifungals, which, by inhibiting the fungal enzyme CYP51, prevent the accumulation of fungitoxic sterols [11,34].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In most clinical practice guidelines, oral fluconazole is recommended as the first-line treatment.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Pappas et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For invasive candidiasis, echinocandins were a great development that lowered the mortality associated with these infections, with low toxicity and few interactions with other medication (Mora-Duarte et al., 2002; Pappas et al., 2016).”
From Fungal Cell Wall: Emerging Antifungals and Drug Resistance. (2019) · cites this paper as Pappas et al., 2016
Experimental — accuracy not yet measured
28 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 564
Predictors and Outcomes of Candiduria in Renal Transplant Recipients
Safdar, N., Slattery, W. R., Knasinski, V., Gangnon, R. E., Li, Z., Pirsch, J. D., & Andes, D. (2005) · Clinical Infectious Diseases · doi:10.1086/429620 · Cited by 152
Self-citationKrishna, G., Ma, L., Martinho, M., & O'Mara, E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00222-12 · Cited by 146
Pulmonary disease caused by Candida species
Masur, H., Rosen, P. P., & Armstrong, D. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90546-0 · Cited by 146
De Wet, N. T. E., Bester, A. J., Viljoen, J. J., Filho, F., Suleiman, J. M., Ticona, E., Llanos, E. A., Fisco, C., Lau, W., & Buell, D. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02427.x · Cited by 145
Krishna, G., Ma, L., Martinho, M., Preston, R. A., & O'Mara, E. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks268 · Cited by 145
McMullan, R., Metwally, L., Coyle, P. V., Hedderwick, S., McCloskey, B., O'Neill, H. J., Patterson, C. C., Thompson, G., Webb, C. H., & Hay, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/528690 · Cited by 145
Espinel-Ingroff, A., Barchiesi, F., Cuenca-Estrella, M., Pfaller, M. A., Rinaldi, M., Rodriguez-Tudela, J. L., & Verweij, P. E. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3884-3889.2005 · Cited by 140
Candida Infective Endocarditis: Report of 15 Cases From a Prospective Multicenter Study
Falcone, M., Barzaghi, N., Carosi, G., Grossi, P., Minoli, L., Ravasio, V., Rizzi, M., Suter, F., Utili, R., Viscoli, C., et al. (2009) · Medicine · doi:10.1097/md.0b013e3181a693f8 · Cited by 138
O'Horo, J. C., Silva, G. L. M., Munoz-Price, L. S., & Safdar, N. (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/664496 · Cited by 138
Groll, A. H., Mickiene, D., Petraitiene, R., Petraitis, V., Lyman, C. A., Bacher, J. S., Piscitelli, S. C., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2845-2855.2001 · Cited by 138
Self-citationOphthalmologic, Visceral, and Cardiac Involvement in Neonates with Candidemia
Noyola, D. E., Fernandez, M., Moylett, E. H., & Baker, C. J. (2001) · Clinical Infectious Diseases · doi:10.1086/319601 · Cited by 137 · cited 1×
“Most of the cases reported in the literature have been treated with AmB deoxycholate, with or without flucytosine [339, 342, 349–355].”
BackgroundPharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age
Sáez-Llorens, X., Macias, M., Maiya, P., Pineros, J., Jafri, H. S., Chatterjee, A., Ruiz, G., Raghavan, J., Bradshaw, S. K., Kartsonis, N. A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00868-08 · Cited by 137
Caspofungin for the treatment of less common forms of invasive candidiasis
Cornely, O. A., Lasso, M., Betts, R., Klimko, N., Vazquez, J., Dobb, G., Velez, J., Williams-Diaz, A., Lipka, J., Taylor, A., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm169 · Cited by 137
Self-citationEffect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers
Lange, D., Pavao, J. H., Wu, J., & Klausner, M. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04332.x · Cited by 136
Diagnosis, management and outcome of Candida endocarditis
Lefort, A., Chartier, L., Sendid, B., Wolff, M., Mainardi, J., Podglajen, I., Desnos‐Ollivier, M., Fontanet, A. L., Bretagne, S., & Lortholary, O. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03764.x · Cited by 135
Orasch, C., Marchetti, O., Garbino, J., Schrenzel, J., Zimmerli, S., Mühlethaler, K., Pfyffer, G. E., Ruef, C., Fehr, J. S., Zbinden, R., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12440 · Cited by 134
Voriconazole Salvage Treatment of Invasive Candidiasis
Ostrosky-Zeichner, L. L., Lashof, A. M. L. O., Kullberg, B. J., & Rex, J. H. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1014-3 · Cited by 134
Self-citation(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Jaijakul, S., Vazquez, J. A., Swanson, R. N., & Ostrosky-Zeichner, L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis456 · Cited by 134
Self-citationOral manifestations of HIV infection and their correlation with CD4 count
Bodhade, A. S., Ganvir, S. M., & Hazarey, V. K. (2011) · Journal of Oral Science · doi:10.2334/josnusd.53.203 · Cited by 133
Candiduria in Hospital Patients: A Study Prospective
Kobayashi, C. C. B. A., Fernandes, O. D. F. L., Miranda, K. C., de Sousa, E. D., & Silva, M. D. R. R. (2004) · Mycopathologia · doi:10.1023/b:myco.0000038436.51918.d9 · Cited by 133
Candidemia from a Urinary Tract Source: Microbiological Aspects and Clinical Significance
Ang, B. S. P., Telenti, A., King, B., Steckelberg, J. M., & Wilson, W. R. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.662 · Cited by 132 · cited 1×
“Several reports have documented a high rate of candidemia when patients undergo urinary tract instrumentation [485, 486], which has led to recommendations to treat with antifungal agents periprocedure.”
BackgroundTreatment of candidaemia in premature infants: comparison of three amphotericin B preparations
Linder, N. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg419 · Cited by 132
Pfaller, M. A., Castanheira, M., Messer, S. A., Moet, G. J., & Jones, R. N. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.08.013 · Cited by 131
Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
Benjamin, D. K., Smith, P. B., Arrieta, A., Castro, L., Sánchez, P. J., Kaufman, D., Arnold, L. J., Kovanda, L. L., Sawamoto, T., Buell, D. N., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.200 · Cited by 131
Self-citationEllis, M., al-Ramadi, B., Finkelman, M., Hedstrom, U., Kristensen, J., Ali-Zadeh, H., & Klingspor, L. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47479-0 · Cited by 131
de Ruiter, J., Weel, J. F. L., Manusama, E. R., Kingma, W. P., & van der Voort, P. H. J. (2009) · Infection · doi:10.1007/s15010-009-8249-6 · Cited by 131
Candida spp. with Acquired Echinocandin Resistance, France, 2004–20101
Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110556 · Cited by 130 · cited 2×
“glabrata [85, 86].”
Pfaller, M. A., Andes, D., Arendrup, M. C., Diekema, D. J., Espinel-Ingroff, A., Alexander, B. D., Brown, S. D., Chaturvedi, V., Fowler, C. L., Ghannoum, M. A., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.03.002 · Cited by 130 · cited 3×
“glabrata [47, 177–179].”
BackgroundSelf-citationHamet, M., Pavon, A., Dalle, F., Péchinot, A., Prin, S., Quenot, J., & Charles, P. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2584-2 · Cited by 129
Kontoyiannis, D. P., Luna, M. A., Samuels, B. I., & Bodey, G. P. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70128-8 · Cited by 129
Population Pharmacokinetics of Micafungin in Neonates and Young Infants
Hope, W. W., Smith, P. B., Arrieta, A., Buell, D. N., Roy, M., Kaibara, A., Walsh, T. J., Cohen-Wolkowiez, M., & Benjamin, D. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01679-09 · Cited by 129
Self-citationGroll, A. H., Mickiene, D., Petraitis, V., Petraitiene, R., Ibrahim, K. H., Piscitelli, S. C., Bekersky, I., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3322-3327.2001 · Cited by 128
Self-citationPharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life
Saxén, H., Hoppu, K., & Pohjavuori, M. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.147 · Cited by 127 · cited 1×
“Thus, a daily fluconazole dose of 12 mg/kg is necessary for neonates and children [102–105].”
BackgroundHealy, C. M., Baker, C. J., Zaccaria, E., & Campbell, J. R. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.016 · Cited by 127
Donders, G., Bellen, G., Byttebier, G., Verguts, L., Hinoul, P., Walckiers, R., Stalpaert, M., Vereecken, A., & Van Eldere, J. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.029 · Cited by 127
Cruciani, M., de Lalla, F., & Mengoli, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2794-y · Cited by 127
A meta-analysis of medical versus surgical therapy for Candida endocarditis
Steinbach, W. J., Perfect, J. R., Cabell, C. H., Fowler, V. G., Corey, G. R., Li, J. S., Zaas, A. K., & Benjamin, D. K. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.10.016 · Cited by 127
Cartledge, J. D., Midgely, J., & Gazzard, B. G. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.6.477 · Cited by 126
Pharmacokinetics of Amphotericin B in Infants and Children
Starke, J. R., Mason, E. O., Kramer, W. G., & Kaplan, S. L. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.4.766 · Cited by 126
Fluconazole Loading Dose Pharmacokinetics and Safety in Infants
Piper, L., Smith, P. B., Hornik, C. P. V., Cheifetz, I. M., Barrett, J. S., Moorthy, G., Hope, W. W., Wade, K. C., Cohen‐Wolkowiez, M., & Benjamin, D. K. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318202cbb3 · Cited by 126
Hanson, K. E., Pfeiffer, C. D., Lease, E. D., Balch, A. H., Zaas, A. K., Perfect, J. R., & Alexander, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042282 · Cited by 122
Fernández-Ruiz, M., Aguado, J. M., Almirante, B., Lora-Pablos, D., Padilla, B., Puig-Asensio, M., Montejo, M., García-Rodríguez, J., Pemán, J., Ruiz Pérez de Pipaón, M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu158 · Cited by 122
CNS pharmacokinetics of antifungal agents
Kethireddy, S., & Andes, D. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425225.3.4.573 · Cited by 122
Self-citationDeterminants of Candidemia and Candidemia-Related Death in Cardiothoracic ICU Patients
Michalopoulos, A. S., Geroulanos, S., & Mentzelopoulos, S. D. (2003) · Chest · doi:10.1378/chest.124.6.2244 · Cited by 121 · cited 1×
“These studies are characterized by high specificity, but low sensitivity, thus missing many patients with candidiasis [240–242].”
BackgroundOstrosky-Zeichner, L., Pappas, P. G., Shoham, S., Reboli, A., Barron, M. A., Sims, C., Wood, C., & Sobel, J. D. (2011) · Mycoses · doi:10.1111/j.1439-0507.2009.01756.x · Cited by 121
Self-citationSafety and pharmacokinetics of fluconazole in children with neoplastic diseases
Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81975-4 · Cited by 120
Pulmonary Candidiasis in Patients with Cancer: An Autopsy Study
Kontoyiannis, D. P., Reddy, B. T., Torres, H. A., Luna, M., Lewis, R. E., Tarrand, J., Bodey, G. P., & Raad, I. I. (2002) · Clinical Infectious Diseases · doi:10.1086/338404 · Cited by 120
Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis
Yera, H., Sendid, B., Francois, N., Camus, D., & Poulain, D. (2001) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s100960100629 · Cited by 119 · cited 1×
“was positive before blood culture in 73% of patients [141].”
BackgroundMasood, A., & Sallah, S. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.10.003 · Cited by 119
Grim, S. A., Berger, K., Teng, C., Gupta, S., Layden, J. E., Janda, W. M., & Clark, N. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr511 · Cited by 118
Usami, M., Ohata, A., Horiuchi, T., Nagasawa, K., Wakabayashi, T., & Tanaka, S. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00162.x · Cited by 117
Fungal Periprosthetic Hip and Knee Joint Infections
Anagnostakos, K., Kelm, J., Schmitt, E., & Jung, J. (2011) · The Journal of Arthroplasty · doi:10.1016/j.arth.2011.04.044 · Cited by 117
Shah, C. P., McKey, J., Spirn, M. J., & Maguire, J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.133405 · Cited by 117
The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent
Purkins, L., Wood, N., Greenhalgh, K., Eve, M. D., Oliver, S. D., & Nichols, D. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01992.x · Cited by 116
Alexander, B. D., Smith, P. B., Davis, R. D., Perfect, J. R., & Reller, L. B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01183-10 · Cited by 116
Philpott-Howard, J. N., Wade, J. J., Mufti, G. J., Brammer, K. W., & Ehniniger, G. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.6.973 · Cited by 114
1,3-β-D-Glucan in Patients Receiving Intravenous Amoxicillin–Clavulanic Acid
Mennink‐Kersten, M. A. S. H., Warris, A., & Verweij, P. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmc053340 · Cited by 114
New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis
Rammaert, B., Desjardins, A., & Lortholary, O. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02182.x · Cited by 113
Jacobs, L. G., Skidmore, E. A., Freeman, K., Lipschultz, D., & Fox, N. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.1.30 · Cited by 113
Risk Factors and Outcomes of Fungal Ventricular‐Assist Device Infections
Aslam, S., Hernandez, M., Thornby, J., Zeluff, B., & Darouiche, R. O. (2010) · Clinical Infectious Diseases · doi:10.1086/650454 · Cited by 113
Meningitis Caused by Candida Species: An Emerging Problem in Neurosurgical Patients
Nguyen, M. H., & Yu, V. L. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.323 · Cited by 113
Garnacho-Montero, J., Diaz-Martin, A., Garcia-Cabrera, E., Ruiz Perez de Pipaon, M., Hernandez-Caballero, C., & Lepe-Jimenez, J. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks347 · Cited by 112
Adverse Effects of Voriconazole: Analysis of the French Pharmacovigilance Database
Eiden, C., Peyrière, H., Cociglio, M., Djezzar, S., Hansel, S., Blayac, J., & Hillaire‐Buys, D. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h671 · Cited by 112
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies
Prella, M., Billé, J., Pugnale, M., Duvoisin, B., Cavassini, M. L., Calandra, T., & Marchetti, O. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.08.015 · Cited by 111
Effect of Botulinum Toxin Type A on a Rat Surgical Wound Model
Lee, B., Jeong, J.-H., Wang, S., Lee, J., Goh, E., & Kim, H.-W. (2009) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2009.2.1.20 · Cited by 111
Uko, S., Soghier, L. M., Vega, M., Marsh, J., Reinersman, G. T., Herring, L., Dave, V. A., Nafday, S., & Brion, L. P. (2006) · Pediatrics · doi:10.1542/peds.2005-1969 · Cited by 111
Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis
Muehrcke, D. D., Lytle, B. W., & Cosgrove, D. M. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00469-2 · Cited by 110 · cited 2×
“propensity to relapse months to years later, follow-up should be maintained for several years after treatment [350, 351].”
BackgroundMohr, J. F., Sims, C., Paetznick, V., Rodriguez, J., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01240-10 · Cited by 110
Self-citationReview of the safety and efficacy of voriconazole
Rathbun, R. C., & Hoffman, H. L. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.3.409 · Cited by 110
Walsh, T. J., Whitcomb, P., Piscitelli, S., Figg, W. D., Hill, S., Chanock, S. J., Jarosinski, P., Gupta, R., & Pizzo, P. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1944 · Cited by 109
Self-citationCandida Prosthetic Valve Endocarditis: Prospective Study of Six Cases and Review of the Literature
Nguyen, M. H., Nguyen, M. L., Vu, V. L., McMahon, D., Keys, T. F., & Amidi, M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.262 · Cited by 109
Echinocandins for Candidemia in Adults without Neutropenia
Bennett, J. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmct060052 · Cited by 109
Beyda, N. D., Lewis, R. E., & Garey, K. W. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1r020 · Cited by 109 · cited 1×
“glabrata, clearly has been documented, and this finding appears to be associated with worse clinical outcomes [10, 12, 35–37, 181, 182].”
BackgroundSafdar, A., Ma, J., Saliba, F., Dupont, B., Wingard, J. R., Hachem, R. Y., Mattiuzzi, G. N., Chandrasekar, P. H., Kontoyiannis, D. P., Rolston, K. V., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181e9441b · Cited by 108
Self-citationWhat Is the Success of Treatment of Hip and Knee Candidal Periprosthetic Joint Infection?
Ueng, S. W., Lee, C., Hu, C.-C., Hsieh, P., & Chang, Y. (2013) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-013-3007-6 · Cited by 107
Safdar, A., Hanna, H. A., Boktour, M. R., Kontoyiannis, D. P., Hachem, R. Y., Lichtiger, B., Freireich, E. J., & RAAD, I. I. (2004) · Cancer · doi:10.1002/cncr.20710 · Cited by 107
Elevation of Blood (1→3)-Beta-D-Glucan Concentrations in Hemodialysis Patients
Kato, A., Takita, T., Furuhashi, M., Takahashi, T., Maruyama, Y., & Hishida, A. (2001) · Nephron · doi:10.1159/000046037 · Cited by 106
Boric Acid for Recurrent Vulvovaginal Candidiasis: The Clinical Evidence
Iavazzo, C., Gkegkes, I. D., Zarkada, I. M., & Falagas, M. E. (2011) · Journal of Women's Health · doi:10.1089/jwh.2010.2708 · Cited by 105
Espinel-Ingroff, A., Pfaller, M. A., Bustamante, B., Canton, E., Fothergill, A., Fuller, J., Gonzalez, G. M., Lass-Flörl, C., Lockhart, S. R., Martin-Mazuelos, E., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02615-13 · Cited by 105 · cited 1×
“glabrata [47, 177–179].”
Self-citationOxman, D. A., Chow, J. K., Frendl, G., Hadley, S., Hershkovitz, S., Ireland, P., McDermott, L. A., Tsai, K., Marty, F. M., Kontoyiannis, D. P., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq136 · Cited by 105
Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00136-13 · Cited by 105 · cited 1×
“glabrata, clearly has been documented, and this finding appears to be associated with worse clinical outcomes [10, 12, 35–37, 181, 182].”
BackgroundSelf-citationChronic Candidal Meningitis: An Uncommon Manifestation of Candidiasis
Voice, R. A., Bradley, S. F., Sangeorzan, J. A., & Kauffman, C. A. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.1.60 · Cited by 104
Self-citationWilcox, C. M., Darouiche, R. O., Laine, L., Moskovitz, B. L., Mallegol, I., & Wu, J. (1997) · The Journal of Infectious Diseases · doi:10.1086/514028 · Cited by 104
Investigation of the possible association between nosocomial candiduria and candidaemia
Binelli, C. A., Moretti, M. L., Assis, R. S., Sauaia, N., Menezes, P. R., Ribeiro, E., Geiger, D., Mikami, Y., Miyaji, M., Oliveira, M. S., et al. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01435.x · Cited by 104
Martins, M. D., Lozano‐Chiu, M., & Rex, J. H. (1998) · Clinical Infectious Diseases · doi:10.1086/515006 · Cited by 103 · cited 1×
“Decreasing rates of oral carriage of Candida species and a reduced frequency of symptomatic oropharyngeal candidiasis are seen among HIV-infected patients on effective antiretroviral therapy [554].”
BackgroundLitvintseva, A. P., Lindsley, M. D., Gade, L., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit808 · Cited by 102
Hong, Y., Shaw, P. J., Nath, C. E., Yadav, S. P., Stephen, K. R., Earl, J. W., & McLachlan, A. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.935-942.2006 · Cited by 102
Prophylactic Oral Nystatin and Fungal Infections in Very-Low-Birthweight Infants
Sims, M., Yoo, Y., You, H., Salminen, C., & Walther, F. (1988) · American Journal of Perinatology · doi:10.1055/s-2007-999649 · Cited by 101
FACTORS DETERMINING VISUAL OUTCOME IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS
Sallam, A. B., Taylor, S. R. J., Khan, A., McCluskey, P., Lynn, W. A., Manku, K., Pacheco, P. A., & Lightman, S. (2012) · Retina · doi:10.1097/iae.0b013e31822d3a34 · Cited by 101
Vazquez, J., Reboli, A. C., Pappas, P. G., Patterson, T. F., Reinhardt, J., Chin-Hong, P., Tobin, E., Kett, D. H., Biswas, P., & Swanson, R. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-97 · Cited by 101
Self-citationCaspofungin in the Treatment of Symptomatic Candiduria
Sobel, J. D., Bradshaw, S. K., Lipka, C. J., & Kartsonis, N. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510432 · Cited by 101
Self-citationSmith, P. B., Benjamin, D. K., Alexander, B. D., Johnson, M. D., Finkelman, M. A., & Steinbach, W. J. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00025-07 · Cited by 101
Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101
Echinocandins — An Advance in the Primary Treatment of Invasive Candidiasis
Walsh, T. J. (2002) · New England Journal of Medicine · doi:10.1056/nejme020142 · Cited by 100
Self-citationCaspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients
Senn, L., Eggimann, P., Ksontini, R., Pascual, A., Demartines, N., Billé, J., Calandra, T., & Marchetti, O. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1405-8 · Cited by 100
TREATMENT OUTCOMES AFTER PARS PLANA VITRECTOMY FOR ENDOGENOUS ENDOPHTHALMITIS
Zhang, Y., & Wang, W. (2005) · Retina · doi:10.1097/00006982-200509000-00010 · Cited by 99
McDonald, H. M., & Chambers, H. M. (2000) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744900000314 · Cited by 99
Gauthier, G. M., Nork, T. M., Prince, R., & Andes, D. (2005) · Clinical Infectious Diseases · doi:10.1086/431761 · Cited by 99
Self-citationUse of Fluconazole in the Treatment of Candidal Endophthalmitis
Akler, M. E., Vellend, H., McNeely, D. M., Walmsley, S. L., & Gold, W. L. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.657 · Cited by 98
Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans.
Marra, F., Robbins, G. M., Masri, B. A., Duncan, C. P., Wasan, K. M., Kwong, E. H., & Jewesson, P. J. (2001) · Europe PMC (PubMed Central) · Cited by 97
Pharmacokinetics and adverse effects of amphotericin B in infants and children
Koren, G., Lau, A. S. Y., Klein, J., Golas, C. L., Bologa, M., Soldin, S. J., MacLeod, S. M., & Prober, C. G. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80653-x · Cited by 97
Early treatment of candidemia in adults: a review
Ostrosky-Zeichner, L., Kullberg, B. J., Bow, E. J., Hadley, S., León, C., Nucci, M., Patterson, T. F., & Perfect, J. R. (2011) · Medical Mycology · doi:10.3109/13693786.2010.512300 · Cited by 97
Self-citationOutcomes Attributable to Neonatal Candidiasis
Zaoutis, T. E., Heydon, K., Localio, R., Walsh, T. J., & Feudtner, C. (2007) · Clinical Infectious Diseases · doi:10.1086/513196 · Cited by 96
Self-citationChhablani, J. K. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.139 · Cited by 95
Elution and Mechanical Properties of Antifungal Bone Cement
Goss, B. G. S., Lutton, C., Weinrauch, P. C. L., et al. (2007) · The Journal of Arthroplasty · doi:10.1016/j.arth.2006.09.013 · Cited by 94
Reboli, A. C., Shorr, A. F., Rotstein, C., Pappas, P. G., Kett, D. H., Schlamm, H. T., Reisman, A. L., Biswas, P., & Walsh, T. J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-261 · Cited by 94
Self-citationPons, V., Greenspan, D., & Debruin, M. (1993) · PubMed · Cited by 93
Fagan, R. P., Edwards, J. R., Park, B. J., Fridkin, S. K., & Magill, S. S. (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/671724 · Cited by 93
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Marriott, D. J., Playford, E. G., Chen, S., Slavin, M., Nguyen, Q., Ellis, D., Sorrell, T. C., & Study, T. A. C. (2009) · Critical Care · doi:10.1186/cc7964 · Cited by 93
Candida Endophthalmitis: Focus on Current and Future Antifungal Treatment Options
Khan, F. A., Slain, D., & Khakoo, R. A. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.12.1711 · Cited by 93
Leu, H.-S., & Huang, C.-T. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1152 · Cited by 93 · cited 1×
“diduria in 80%–90% of patients, as shown in several open-label trials, but in those studies, recurrent candiduria within several weeks was very common [503–505].”
BackgroundCandidal Meningitis in HIV‐Infected Patients: Analysis of 14 Cases
Casado, J. L., Quereda, C., Oliva, J., Navas, E., Moreno, A., Pintado, V., Cobo, J., & Corral, I. (1997) · Clinical Infectious Diseases · doi:10.1086/513746 · Cited by 93
Hocevar, S. N., Edwards, J. R., Horan, T. C., Morrell, G. C., Iwamoto, M., & Lessa, F. C. (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/668425 · Cited by 92
Hepatosplenic Candidiasis in Patients with Acute Leukemia: Incidence and Prognostic Implications
Anttila, V.-J., Elonen, E., Nordling, S., Sivonen, A., Ruutu, T., & Ruutu, P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.375 · Cited by 91
Slenker, A. K., Keith, S. W., & Horn, D. L. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.004 · Cited by 91
Pharmacokinetics of amphotericin B in children
Benson, J. M., & Nahata, M. C. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1989 · Cited by 91
Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis?
Krishna, R., Amuh, D., Lowder, C. Y., Gordon, S. M., Adal, K. A., & Hall, G. S. (2000) · Eye · doi:10.1038/eye.2000.7 · Cited by 91
Vardakas, K. Z., Samonis, G., Michalopoulos, A., Soteriades, E. S., & Falagas, M. E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000208357.05675.c3 · Cited by 91
Candida prosthetic infections: Case series and literature review
Dutronc, H., Dauchy, F., Cazanave, C., Rougie, C., Lafarie, S., Couprie, B., Fabre, T., & Dupon, M. (2010) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2010.498023 · Cited by 90
Lu, Y., Chen, Y.-Q., Guo, Y.-L., Qin, S.-M., Wu, C., & Wang, K. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.6175 · Cited by 90
Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature
Tunkel, A. R., Thomas, C. Y., & Wispelwey, B. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90127-b · Cited by 90
Antifungal drugs in pregnancy: a review
Moudgal, V. V., & Sobel, J. D. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.5.475 · Cited by 90
Self-citationIntraocular penetration of systemically administered antifungal agents
O'day, D. M., Head, W. S., Robinson, R. D., Stern, W. H., & Freeman, J. M. (1985) · Current Eye Research · doi:10.3109/02713688508999978 · Cited by 90
Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures
Cohen‐Wolkowiez, M., Smith, P. B., Mangum, B., Steinbach, W. J., Alexander, B. D., Cotten, C. M., Clark, R. H., Walsh, T. J., & Benjamin, D. K. (2006) · Journal of Perinatology · doi:10.1038/sj.jp.7211628 · Cited by 89
Self-citationPhillips, P., Zemcov, J., Mahmood, W., Montaner, J. S. G., Craib, K., & Clarke, A. M. (1996) · AIDS · doi:10.1097/00002030-199610000-00009 · Cited by 88 · cited 1×
“Fluconazole-refractory infections should be treated initially with itraconazole solution; between 64% and 80% of patients will respond to this therapy [546, 547].”
BackgroundMartinez‐Vazquez, C., Fernandez‐Ulloa, J., Bordon, J., Sopena, B., la Fuente, J. D., Ocampo, A., & Rubianes, M. (1998) · Clinical Infectious Diseases · doi:10.1086/514972 · Cited by 88
Watson, M. C., Grimshaw, J. M., Bond, C. M., Mollison, J., & Ludbrook, A. (2002) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01142.x · Cited by 87
Patel, P. K., Erlandsen, J. E., Kirkpatrick, W. R., Berg, D. K., Westbrook, S. D., Louden, C., Cornell, J. E., Thompson, G. R., Vallor, A. C., Wickes, B. L., et al. (2012) · AIDS Research and Treatment · doi:10.1155/2012/262471 · Cited by 87
Méar, J.-B., Kipnis, É., Faure, E., Dessein, R., Schurtz, G., Faure, K., & Guery, B. P. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.02.005 · Cited by 86
Targeted Versus Universal Decolonization to Prevent ICU Infection
Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Avery, T. R., Lankiewicz, J., Gombosev, A., Terpstra, L., Hartford, F., et al. (2014) · Survey of Anesthesiology · doi:10.1097/01.sa.0000441041.37323.f9 · Cited by 86
Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Jones, R. N., & Castanheira, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00863-13 · Cited by 85
Airway Fungal Colonization Compromises the Immune System Allowing Bacterial Pneumonia to Prevail
Roux, D., Gaudry, S., Khoy-Ear, L., Aloulou, M., Phillips-Houlbracq, M., Bex-Coudrat, J., Skurnik, D., Denamur, É., Monteiro, R. C., Dreyfuss, D., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828a25d6 · Cited by 85
Declining incidence of AIDS-defining opportunistic illnesses
Schwarcz, L., Chen, M.-J., Vittinghoff, E., Hsu, L. C., & Schwarcz, S. K. (2012) · AIDS · doi:10.1097/qad.0b013e32835b0fa2 · Cited by 84
Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit
Öztürk, M. A., Güneş, T., Köklü, E., Çetin, N., & Koç, N. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01274.x · Cited by 83
Goldman, M. D., Cloud, G. A., Wade, K. D., Reboli, A. C., Fichtenbaum, C. J., Hafner, R., Sobel, J. D., Powderly, W. G., Patterson, T. F., Wheat, L. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497373 · Cited by 83
Self-citationTreatment of Ocular Fungal Infections With Oral Fluconazole
WAN, W. L., Kubak, B., Smith, M. D., OSTER, H. A., & Luttrull, J. K. (1995) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71234-6 · Cited by 82
Antifungal Therapy and Outcomes in Infants With Invasive Candida Infections
Ascher, S. B., Smith, P. B., Watt, K., Benjamin, D. K., Cohen‐Wolkowiez, M., Clark, R. H., Benjamin, D. K., & Moran, C. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182467a72 · Cited by 82
Castanheira, M., Woosley, L. N., Messer, S. A., Diekema, D. J., Jones, R. N., & Pfaller, M. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01674-13 · Cited by 82
Clearance of Intravitreal Voriconazole
Shen, Y.-C., Wang, M.-Y., Wang, C.-Y., Tsai, T.-C., Tsai, H.-Y., Lee, Y., & Wei, L.-C. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1362 · Cited by 80
Schell, W. A., Benton, J. L., Smith, P. B., Poore, M., Rouse, J. L., Boles, D. J., Johnson, M. D., Alexander, B. D., Pamula, V. K., Eckhardt, A. E., et al. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1561-6 · Cited by 79
Saag, M. S., Fessel, W. J., Kaufman, C. A., Merrill, K. W., Ward, D. J., Moskovitz, B. L., Thomas, C., Oleka, N., Guarnieri, J. A., Lee, J., et al. (1999) · AIDS Research and Human Retroviruses · doi:10.1089/088922299309919 · Cited by 79 · cited 2×
“Fluconazole-refractory infections should be treated initially with itraconazole solution; between 64% and 80% of patients will respond to this therapy [546, 547].”
BackgroundBarbaro, G., Barbarini, G., Calderon, W., Grisorio, B., Alcini, P., & Di Lorenzo, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898629 · Cited by 78 · cited 1×
“sules, and flucytosine, and is comparable to itraconazole solution for the treatment of esophageal candidiasis [558, 559]; up to 80% of patients with fluconazole-refractory infections will re-”
BackgroundTrends in Candida Central Line-Associated Bloodstream Infections Among NICUs, 1999–2009
Chitnis, A. S., Magill, S. S., Edwards, J. R., Chiller, T. M., Fridkin, S. K., & Lessa, F. C. (2012) · Pediatrics · doi:10.1542/peds.2011-3620 · Cited by 78
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Hegener, P., Troke, P. F., Fätkenheuer, G., Diehl, V., & Ruhnke, M. (1998) · PubMed · Cited by 78
Candida albicans osteomyelitis: case report and literature review
Arias, F., Mata‐Essayag, S., Landaeta, M. E., de Capriles, C. H., Pérez, C., Núñez, M. J., Carvajal, A., & Silva, M. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.12.006 · Cited by 77
Candida infection of the central nervous system following neurosurgery: a 12-year review
O’Brien, D. J., Stevens, N. T., Lim, C. H., O’Brien, D. F., Smyth, E. G., Fitzpatrick, F., & Humphreys, H. (2011) · Acta Neurochirurgica · doi:10.1007/s00701-011-0990-9 · Cited by 76
INTRAVITREAL VORICONAZOLE FOR DRUG-RESISTANT FUNGAL ENDOPHTHALMITIS
Sen, P., Gopal, L., & Sen, P. R. (2006) · Retina · doi:10.1097/01.iae.0000250011.68532.a2 · Cited by 76
Posaconazole salvage treatment in paediatric patients: a multicentre survey
Lehrnbecher, T., Attarbaschi, A., Dürken, M., Garbino, J., Gruhn, B., Kontny, U., Lüer, S. C., Phillips, B., Scholz, J., Wagner, H. J., et al. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0957-4 · Cited by 76
Candida Antigen Latex Test for Detection of Invasive Candidiasis in Immunocompromised Patients
Ness, M. J., Vaughan, W. P., & Woods, G. L. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.3.495 · Cited by 76
Betts, R., Glasmacher, A., Maertens, J., Maschmeyer, G., Vazquez, J. A., Teppler, H., Taylor, A., Lupinacci, R., Sable, C., & Kartsonis, N. (2006) · Cancer · doi:10.1002/cncr.21615 · Cited by 75
Self-citationOral nystatin prophylaxis and neonatal fungal infections
Howell, A. J., Isaacs, D., Halliday, R. J., & Infections, T. A. S. G. F. N. (2009) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2008.157123 · Cited by 75
Lye, D. C. B., Hughes, A., O'Brien, D., & Athan, E. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0038-2 · Cited by 75
Cannon, J. P., Fiscella, R., Pattharachayakul, S., Garey, K. W., De Alba, F., Piscitelli, S., Edward, D. P., & Danziger, L. H. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1020 · Cited by 74
Delivery of Antifungal Agents Using Bioactive and Nonbioactive Bone Cements
Sealy, P., Nguyen, C. H. T., Tucci, M. A., Benghuzzi, H. A., & Cleary, J. D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m143 · Cited by 74
Driscoll, T. A., Frangoul, H., Nemecek, E. R., Murphey, D. K., Yu, L. C., Blumer, J., Krance, R. A., Baruch, A., & Liu, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05010-11 · Cited by 74
Cm, W., Alexander, L., Clark, W. S., & Thompson, S. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964406 · Cited by 73
Kohno, S., Izumikawa, K., Yoshida, M., Takesue, Y., Oka, S., Kamei, K., Miyazaki, Y., Yoshinari, T., Kartsonis, N. A., & Niki, Y. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1754-z · Cited by 73
Theel, E. S., Jespersen, D. J., Iqbal, S., Bestrom, J. E., Rollins, L. O., Misner, L., Markley, B., Mandrekar, J. N., Baddour, L. M., LIMPER, A. H., et al. (2012) · Mycopathologia · doi:10.1007/s11046-012-9579-y · Cited by 72
Candidal Vertebral Osteomyelitis: Report of 6 Patients, and a Review
Hendrickx, L., Van Wijngaerden, E., Samson, I., & Peetermans, W. E. (2001) · Clinical Infectious Diseases · doi:10.1086/318714 · Cited by 72
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS
Havlir, D. V., Dubé, M. P., McCutchan, J. A., Forthal, D. N., Kemper, C. A., Dunne, M. W., Parenti, D. M., Kumar, P. N., White, A. C., Witt, M. D., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/515018 · Cited by 72 · cited 1×
“Long-term suppressive therapy with fluconazole has been shown to be effective in the prevention of oropharyngeal candidiasis [53, 542, 543].”
BackgroundLouie, A., Liu, W., Miller, D. A., Sucke, A. C., Liu, Q.-F., Drusano, G. L., Mayers, M., & Miller, M. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2831 · Cited by 72
Fungal Eye Disease at a Tertiary Care Center: The Utility of Routine Inpatient Consultation
Dozier, C. C., Tarantola, R. M., Jiramongkolchai, K., & Donahue, S. P. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.038 · Cited by 72
Detection of candidaemia in patients with and without underlying haematological disease
Arendrup, M. C., Bergmann, O. J., Larsson, L., Nielsen, H. V., Jarløv, J. O., & Christensson, B. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02931.x · Cited by 71
Wood, G. C., Mueller, E. W., Croce, M. A., Boucher, B. A., & Fabian, T. C. (2006) · Intensive Care Medicine · doi:10.1007/s00134-005-0065-6 · Cited by 71
Factors associated with candiduria and related mortality
Paul, N., Mathai, E., Abraham, O. C., Michael, J. S., & Mathai, D. C. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.06.010 · Cited by 71
Flucytosine therapeutic monitoring: 15 years experience from the UK
Pasqualotto, A. C., Howard, S. J., Moore, C. B., & Denning, D. W. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl550 · Cited by 71
Phillips, P., De Beule, K., Frechette, G., Tchamouroff, S., Vandercam, B., Weitner, L., Hoepelman, A., Stingl, G., & Clotet, B. (1998) · Clinical Infectious Diseases · doi:10.1086/516342 · Cited by 71
Anttila, V., Lamminen, A., Bondestam, S., et al. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb00300.x · Cited by 71
Candidaurinary tract infections: treatment options
Malani, A. N., & Kauffman, C. A. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.2.277 · Cited by 70
Self-citationMontecalvo, M. A., McKenna, D. F., Yarrish, R. L., Mack, L., Maguire, G. P., Haas, J., DeLorenzo, L. J., Dellarocco, N., Savatteri, B., Rosenthal, A., et al. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.032 · Cited by 70
Vitrectomy for Endogenous Fungal Endophthalmitis
Shen, X. P., & Xu, G. (2009) · Ocular Immunology and Inflammation · doi:10.1080/09273940802689396 · Cited by 70
Treatment Options for Vulvovaginal Candidiasis, 1993
Reef, S. E., Levine, W. C., McNeil, M. M., Fisher-Hoch, S., Holmberg, S. D., Duerr, A., Smith, D., Sobel, J. D., & Pinner, R. W. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_1.s80 · Cited by 70
Self-citationHorn, D. L., Ostrosky-Zeichner, L., Morris, M. I., Ullmann, A. J., Wu, C., Buell, D. N., Kovanda, L. L., & Cornely, O. A. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0843-0 · Cited by 69
Self-citationAdministration of Voriconazole in Patients With Renal Dysfunction
Neofytos, D., Lombardi, L. R., Shields, R. K., Ostrander, D. B., Warren, L., Nguyen, M. H., Thompson, C. B., & Marr, K. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir969 · Cited by 69
Self-citationRisk factors for death among cancer patients with fungemia
Nucci, M., Silveira, M. I., Spector, N., Silveira, F., Velasco, E., Akiti, T., Barreiros, G., Derossi, A., Colombo, A. L., & Pulcheri, W. (1998) · Clinical Infectious Diseases · doi:10.1086/514609 · Cited by 69 · cited 2×
“greater chance of treatment failure [190, 203, 204, 212].”
BackgroundWeitkamp, J.-H., Ozdas, A., LaFleur, B., & Potts, A. L. (2008) · Journal of Perinatology · doi:10.1038/sj.jp.7211914 · Cited by 69
Boland, J. M., Chung, H. H., Robberts, F. J. L., Wilson, W. R., Steckelberg, J. M., Baddour, L. M., & Miller, D. V. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01884.x · Cited by 68
Candida glabrata Endophthalmitis Treated Successfully with Caspofungin
Sarria, J. C., Bradley, J. C., Habash, R., Mitchell, K. T., Kimbrough, R. C., & Vidal, A. M. (2005) · Clinical Infectious Diseases · doi:10.1086/427753 · Cited by 68
Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits.
Tremblay, C., Barza, M. J., Szoka, F. C., Lahav, M., & BAUM, J. L. (1985) · PubMed · Cited by 67
Liu, C. Y., Huang, L. J., Wang, W. S., Chen, T. L., Yen, C. C., Yang, M. H., Hsiao, L. T., Liu, C. Y., Chen, P. M., & Chiou, T. J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.12.008 · Cited by 67
Robinson, J. L., Davies, H. D., Barton, M., O’Brien, K., Simpson, K., Asztalos, E. V., Synnes, A. R., Rubin, E., Saux, N. L., Hui, C. P., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-183 · Cited by 67
Tissue Penetration of Amphotericin B in Candida Endocarditis
Rubinstein, E., Rodríguez-Noriega, E., Simberkoff, M. S., & Rahal, J. J. (1974) · CHEST Journal · doi:10.1378/chest.66.4.376 · Cited by 66
Petraitienė, R., Petraitis, V., Hope, W. W., Mickiene, D., Kelaher, A. M., Murray, H. A., Mya-San, C., Hughes, J. E., Cotton, M. P., Bacher, J. D., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00674-08 · Cited by 66
Self-citationApproach to the Diagnosis of Invasive Aspergillosis and Candidiasis
Wheat, L. J. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.012 · Cited by 65
Excess Costs of Hospital Care Associated With Neonatal Candidemia
Smith, P. B., Morgan, J., Benjamin, D. K., Fridkin, S. K., Sanza, L. T., Harrison, L. H., Sofair, A. N., Huie-White, S., & Benjamin, D. K. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253973.89097.c0 · Cited by 65
Is It Time to Abandon the Use of Amphotericin B Bladder Irrigation?
Drew, R. H., Arthur, R. R., & Perfect, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/429722 · Cited by 64
How to diagnose and treat fungal infections in chronic prostatitis
Wise, G. J., & Shteynshlyuger, A. (2006) · Current Urology Reports · doi:10.1007/s11934-996-0012-2 · Cited by 64
Quantitative Blood Cultures in Candidemia
Telenti, A., Steckelberg, J. M., Stockman, L., Edson, R. S., & Roberts, G. D. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65791-7 · Cited by 64
Driscoll, T. A., Yu, L. C., Frangoul, H., Krance, R. A., Nemecek, E., Blumer, J., Arrieta, A., Graham, M. L., Bradfield, S. M., Baruch, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00531-11 · Cited by 64
Candida albicans Prosthetic Arthritis Treated with Fluconazole Alone
Merrer, J., Dupont, B., Nieszkowska, A., Jonghe, B. D., & Outin, H. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0819 · Cited by 63
Goldblum, D., Rohrer, K., Frueh, B. E., Theurillat, R., Thormann, W., & Zimmerli, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3719-3723.2002 · Cited by 63
Clancy, C. J., Nguyen, M.-L., Cheng, S., Huang, H., Fan, G., Jaber, R. A., Wingard, J. R., Cline, C., & Nguyen, M. H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02018-07 · Cited by 62
Self-citationCandida albicans Sternal Wound Infections: A Chronic and Recurrent Complication of Median Sternotomy
Malani, P. N., McNeil, S. A., Bradley, S. F., & Kauffman, C. A. (2002) · Clinical Infectious Diseases · doi:10.1086/344192 · Cited by 62 · cited 2×
“nitis and sternal osteomyelitis in patients who have undergone sternotomy can be treated successfully with surgical debridement followed by either AmB or fluconazole [391, 399].”
BackgroundSelf-citationPfaller, M. A., Castanheira, M., Diekema, D. J., Messer, S. A., & Jones, R. N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05047-11 · Cited by 62
Ruiz, L. D. S., Khouri, S., Hahn, R. C., Silva, E. G., Oliveira, V. K. P., Gandra, R. F., & Paula, C. R. (2013) · Mycopathologia · doi:10.1007/s11046-013-9616-5 · Cited by 61
Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02161-10 · Cited by 61
Hennequin, C., Bouree, P., Hiesse, C., Dupont, B., & Charpentier, B. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.176 · Cited by 61
Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections
White, D. J. (2001) · Sexually Transmitted Infections · doi:10.1136/sti.77.3.212 · Cited by 61
Outcomes Following Candiduria in Extremely Low Birth Weight Infants
Wynn, J. L., Tan, S., Gantz, M. G., Das, A., Goldberg, R. N., Adams-Chapman, I., Stoll, B. J., Shankaran, S., Walsh, M. C., Auten, K. J., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir800 · Cited by 60
Tacke, D., Koehler, P. A., & Cornely, O. A. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000009 · Cited by 60
Research works printed but not linked: 1
- Sobel, 2002, Controversies in the diagnosis of candiduria: what is the critical colony count?, Curr Treatment Options Infect Dis, 4, 81
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“Empiric use of an echinocandin (anidulafungin, micafungin, or caspofungin) is preferred in most patients with severe illness, especially in those patients with septic shock, who have recently been treated with other antifungal agents, or if Candida glabrata or Candida krusei infection is suspected from earlier culture…”
BackgroundInfluentialSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Self-citation
Metadata
- Authors
- Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., Zaoutis, T. E., & Sobel, J. D.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Michigan (US)
- University of Wisconsin–Madison (US)
- University of Pittsburgh (US)
- Johns Hopkins University (US)
- University of Texas Health Science Center, Houston
- Cooper Medical School of Rowan University (US)
- University of Pennsylvania (US)
- Georgia Regents University, Augusta
- Cornell University (US)
- Children's Hospital of Pennsylvania, Philadelphia
- Wayne State University (US)
- Corresponding author
- Pappas, Peter G.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12-16
- Volume
- 62
- Issue
- 4
- Pages
- e1-e50
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4725385
- OpenAlex
- W2216117396
- Semantic Scholar
- 32a81df25cfe286355f8b42bb1a020d93fa4673f
- Cited by
- 4,200
- References
- 564
- Citations by year
- 2026: 477 · 2025: 520 · 2024: 424 · 2023: 464 · 2022: 422 · 2021: 456 · 2020: 388 · 2019: 322 · 2018: 332 · 2017: 261 · 2016: 124 · 2015: 1
- FWCI
- 185.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- the Infectious Diseases Society of America
- National Institutes of Health
- NIH
- National Institute of Dental and Craniofacial Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- candidiasis, antifungal therapy, fungal infection, clinical management, treatment guidelines
- MeSH terms
- Animals, Antifungal Agents, Candidiasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.